贝叶斯华法林剂量个体化与标准治疗的随机对照试验
一项前瞻性、双臂、单盲随机对照试验纳入240例心脏术后接受华法林治疗的成人,比较基于药代药效学模型的网络剂量计算器(NextDose)与标准临床管理。NextDose组在整个随访期%TIR更高(74 vs. 71%,P=0.04),临床相关轻微出血风险更低(HR 0.21,P=0.041),但前28天%TIR差异无统计学意义(63 vs. 56%,P=0.13)。
要点
- NextDose指导可提高心脏术后华法林全程%TIR并减少轻微出血。
- 前28天%TIR有升高趋势但未达统计学显著(63 vs. 56%,P=0.13)。
- 89.3%的NextDose推荐剂量被处方者接受,实用可行。
核心结论
- 基于药代药效学理论的NextDose指导华法林剂量管理可提高全程%TIR并减少出血事件。
研究设计与样本
- 前瞻性、双臂、单盲随机对照试验,纳入240例心脏术后接受华法林治疗的成人,随访至华法林起始后至少3个月的首个门诊。
主要发现
- 前28天%TIR中位数NextDose组63% vs. 标准治疗组56%,P=0.13。
- 整个随访期%TIR中位数NextDose组74% vs. 标准治疗组71%,P=0.04。
- 临床相关轻微出血事件风险NextDose组更低,风险比0.21,P=0.041。
- NextDose组中89.3%的推荐剂量被处方者接受。
临床怎么用
- 对于心脏术后需华法林治疗的患者,可考虑采用基于模型的剂量计算器辅助个体化给药。
- 该策略有望减少对临床经验的依赖,提高抗凝质量。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The quality of warfarin treatment may be improved if management is guided by the use of models based upon pharmacokinetic-pharmacodynamic theory. A prospective, two-armed, single-blind, randomized controlled trial compared management aided by a web-based dose calculator (NextDose) with standard clinical care. Participants were 240 adults receiving warfarin therapy following cardiac surgery, followed up until the first outpatient appointment at least 3 months after warfarin initiation. We compared the percentage of time spent in the international normalized ratio acceptable range (%TIR) during the first 28 days following warfarin initiation, and %TIR and count of bleeding events over the entire follow-up period. Two hundred thirty-four participants were followed up to day 28 (NextDose: 116 and standard of care: 118), and 228 participants (114 per arm) were followed up to the final study visit. Median %TIR tended to be higher for participants receiving NextDose guided warfarin management during the first 28 days (63 vs. 56%, P = 0.13) and over the entire follow-up period (74 vs. 71%, P = 0.04). The hazard of clinically relevant minor bleeding events was lower for participants in the NextDose arm (hazard ratio: 0.21, P = 0.041). In NextDose, there were 89.3% of proposed doses accepted by prescribers. NextDose guided dose management in cardiac surgery patients requiring warfarin was associated with an increase in %TIR across the full follow-up period and fewer hemorrhagic events. A theory-based, pharmacologically guided approach facilitates higher quality warfarin anticoagulation. An important practical benefit is a reduced requirement for clinical experience of warfarin management.
引用
- Xue L, Ma G, Holford N, et al. A Randomized Trial Comparing Standard of Care to Bayesian Warfarin Dose Individualization. Clin Pharmacol Ther. 2024. PMID: 38439157. doi:10.1002/cpt.3207
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。